Money matters: does the reimbursement policy for second-generation antipsychotics influence the number of recorded schizophrenia patients and the burden of stigmatization?

By Kiejna Andrzej   Misiak Blazej   Zagdanska Marta   Drapala Jaroslaw   Piotrowski Patryk   Szczesniak Dorota   Chladzinska-Kiejna Sylwia   Cialkowska-Kuzminska Magdalena   Frydecka Dorota  

Social Psychiatry and Psychiatric Epidemiology, Vol. 49, Iss. 4, 2014-04 ,pp. : 531-539

Springer Publishing Company

Access to resources Recommend Favorite

Rehospitalization Risk with Second-Generation and Depot Antipsychotics

By Conley R.R.  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 15, Iss. 1, 2003-03 ,pp. : 23-31

Springer Publishing Company

Access to resources Recommend Favorite

Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment

By Mahmoud Ahmed  

Primary Care Psychiatry, Vol. 16, Iss. 2, 2012-06 ,pp. : 148-152

Informa Healthcare

Access to resources Recommend Favorite

Sexual function of patients with schizophrenia receiving first-generation (FGA) or second-generation antipsychotic (SGA) treatment

By Mahmoud Ahmed   Hayhurst Karen P.   Drake Richard J.   Lewis Shôn W.  

International Journal of Psychiatry in Clinical Practice, Vol. 16, Iss. 2, 2012-06 ,pp. : 148-152

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics

By De Nayer A   Larmo I   Lindenbauer B   Rittmannsberger H   Platz T   Jones Am   Whiteford Jl   Altman Ca   Windhager E    

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 1, 2003-01 ,pp. : 59-66

Ashgate Publishing Ltd

Access to resources Recommend Favorite